15-31483730-T-TCGTCCCGCGCGCCC
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_001382637.1(OTUD7A):c.2365_2366insGGGCGCGCGGGACG(p.Glu789GlyfsTer203) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 31)
Consequence
OTUD7A
NM_001382637.1 frameshift
NM_001382637.1 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.60
Genes affected
OTUD7A (HGNC:20718): (OTU deubiquitinase 7A) The protein encoded by this gene is a deubiquitinizing enzyme and possible tumor suppressor. The encoded protein acts on TNF receptor associated factor 6 (TRAF6) to control nuclear factor kappa B expression. However, this gene is downregulated by SNAIL1 in hepatocellular carcinoma cells, contributing to their progression and malignancy. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PVS1
?
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.718 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
?
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OTUD7A | NM_001382637.1 | c.2365_2366insGGGCGCGCGGGACG | p.Glu789GlyfsTer203 | frameshift_variant | 13/13 | ENST00000307050.6 | |
OTUD7A | NM_130901.3 | c.2344_2345insGGGCGCGCGGGACG | p.Glu782GlyfsTer203 | frameshift_variant | 14/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OTUD7A | ENST00000307050.6 | c.2365_2366insGGGCGCGCGGGACG | p.Glu789GlyfsTer203 | frameshift_variant | 13/13 | 1 | NM_001382637.1 | P2 | |
OTUD7A | ENST00000560598.2 | c.2344_2345insGGGCGCGCGGGACG | p.Glu782GlyfsTer203 | frameshift_variant | 14/14 | 5 | A2 | ||
OTUD7A | ENST00000678495.1 | c.2344_2345insGGGCGCGCGGGACG | p.Glu782GlyfsTer203 | frameshift_variant | 11/11 | A2 |
Frequencies
GnomAD3 genomes ? Cov.: 31
GnomAD3 genomes
?
Cov.:
31
GnomAD4 exome Cov.: 28
GnomAD4 exome
Cov.:
28
GnomAD4 genome ? Cov.: 31
GnomAD4 genome
?
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
OTUD7A-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 30, 2023 | The OTUD7A c.2331_2344dup14 variant is predicted to result in a frameshift and premature protein termination (p.Glu782Glyfs*203). which is predicted to result in an extension of the normal reading frame (p.Glu782Glyfs*203). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.